Massachusetts Eye Research and Surgery Institution — Cambridge, Massachusetts

Massachusetts Eye Research and Surgery Institution is a clinical research site located in Cambridge, Massachusetts, United States 02142.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Massachusetts Eye Research and Surgery Institution has participated in 4 clinical trials.

Therapeutic areas: Anterior Uveitis, Neurotrophic Keratitis, Uveitis, Anterior.

Sponsors: Eyegate Pharmaceuticals, Inc., Dompé Farmaceutici S.p.A, Aciont Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Cambridge

Browse all research sites in Massachusetts · View every site in Cambridge

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachusetts Eye Research and Surgery Institution?

Massachusetts Eye Research and Surgery Institution has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachusetts Eye Research and Surgery Institution conducted?

Massachusetts Eye Research and Surgery Institution has 4 clinical trials on record. Their work covers Anterior Uveitis, Neurotrophic Keratitis, Uveitis, Anterior.

Is Massachusetts Eye Research and Surgery Institution accredited by Crixeo Clinical Trials?

Massachusetts Eye Research and Surgery Institution has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Massachusetts Eye Research and Surgery Institution?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.